Biological Therapeutics Product Development Subject Matter Expert Consulting Services
The National Institutes of Health (NIH) is conducting a market survey to identify qualified small businesses that can provide subject matter expert consultants for gene-based therapeutics development, offering technical recommendations to support NIH drug discovery and development programs. The government is seeking capability statements from interested firms, including 8(a), small disadvantaged, woman-owned, service-disabled veteran-owned, and HUBZone businesses. The requirement falls under NAICS code 541690 with a size standard of $19 million, and respondents must demonstrate their experience and technical capability in sufficient detail for evaluation. No specific performance location or budget figures are mentioned in the notice. This is a planning effort only, not a commitment by the government to award a contract.